During Open Access Week 2020, and one year after the launch of the Open Pharma position statement, we bring together stakeholders from different backgrounds to share their perspectives on open access in the pharma industry. Join us for a panel discussion, led by Chris Winchester from Oxford PharmaGenesis, and featuring Durhane Wong-Rieger from the Canadian Organization for Rare Disorders, Valerie Philippon from Takeda and Gavin Sharrock from Wiley, to find out why and how you can make a difference within your organization.
- Questions from the audience will be welcomed.
- It should be of interest to anyone working in and around MedComms and wanting to challenge conventional working practices.
- The webinar is free of charge and, all being well, a recording will be posted afterwards at NetworkPharma.tv.
- Note we are allowing 60 minutes for the webinar and we always aim to finish promptly on time.
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.